摘要
人类多发性骨髓瘤是一种难以治愈的B淋巴细胞恶性分化的疾病,其细胞遗传学特征表现在染色体异常.原癌基因c-maf在多发性骨髓瘤细胞中高水平表达,其编码的c-Maf蛋白作为转录因子,通过作用于5个下游靶基因CCND2、ITGB7、CCR1、SPP1和ARK5,与细胞周期调控、肿瘤细胞的黏附性、肿瘤侵袭和转移、血管发生等方面有关.原癌基因c-maf和/或c-Maf蛋白有可能作为治疗多发性骨髓瘤的新靶点.
Human multiple myeloma is an incurable disease of malignant differentiated B lymphocytes. Its cytogenetics is characterised by chromosomal abnormalities. The c-maf proto-oncogene is expressed at high level in multiple myeloma cells. As a transcription factor, the c-Mar protein through the five downstream target genes: CCND2, 1TGB7, CCR1, SPP1 and ARKS, is involved in cell cycle regulation, adhesion of tumor cells, tumor invasion and metastasis, angiogenesis and other aspects. The c-mar proto-oncogene and/ or c-Maf protein may be a novel therapeutic target in multiple myeloma.
出处
《生命科学研究》
CAS
CSCD
2009年第6期554-557,共4页
Life Science Research
基金
国家自然科学基金资助项目(30770906)